SCHEMBL26505596

SCHEMBL26505596

CC(C)c1cc(F)ccc1-c1cnn(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR55 Q9Y2T6 1/20 0.46
▸ ALOX5AP P20292 1/20 0.43
▸ FEN1 P39748 1/20 0.43
▸ NTRK1 P04629 2/20 0.43
▸ NTRK3 Q16288 2/20 0.43
▸ LRRK2 Q5S007 1/20 0.42
▸ ALK Q9UM73 2/20 0.41
▸ IRAK1 P51617 1/20 0.41
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ CLK1 P49759 1/20 0.41
▸ DYRK1A Q13627 1/20 0.41
▸ BRD4 O60885 1/20 0.39
▸ PDE9A O76083 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ USP30 Q70CQ3 1/20 0.38
▸ MET P08581 2/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23761250 0.88 ALOX5AP (0.44) GPR55ALOX5APFEN1NTRK1NTRK3
SCHEMBL10094405 0.88 GPR55 (0.46) GPR55ALOX5APFEN1NTRK1NTRK3
SCHEMBL21901803 0.83 LRRK2 (0.49) ALOX5APFEN1LRRK2IRAK1IRAK4
SCHEMBL17661854 0.82 FGFR3 (0.48) ALOX5APFEN1LRRK2IRAK1IRAK4
SCHEMBL17806620 0.80 ALOX5AP (0.41) GPR55ALOX5APFEN1LRRK2IRAK1
SCHEMBL20754515 0.79 ALOX5AP (0.42) GPR55ALOX5APFEN1NTRK1NTRK3
SCHEMBL10094326 0.78 BRD4 (0.50) ALOX5APFEN1IRAK1IRAK4BRD4
SCHEMBL18124158 0.78 TGFBR1 (0.48) GPR55ALOX5APFEN1NTRK1NTRK3
SCHEMBL17806593 0.77 KCNH2 (0.49) GPR55ALOX5APFEN1CLK1DYRK1A
SCHEMBL17806580 0.77 IDH1 (0.45) ALOX5APFEN1LRRK2DYRK1ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230139111-A1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2023-05-04 — — US disclosed
US-20230139111-A1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139111-A1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF RIPK1, RIPK4, RIPK3 GPR55 2326/4885ALOX5AP 2750/4885FEN1 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback